Effect of Yellow Light AG Mobile Phone Screen on Dry Eye and Asthenopia.

NCT ID: NCT07340359

Last Updated: 2026-01-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-24

Study Completion Date

2026-01-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aimed to evaluate the protective effects of yellow-light etching anti-glare (AG) screen on Digital Eye Strain (DES) induced by prolonged video display terminal (VDT) use under dim environment, Based on the proved positive effect of the circular polarization (CP) screen, providing insights for new eye-protection strategy in the highly digital modern era. In a randomized, double-blind controlled trial, 70 eligible volunteers (diopter ≤ -6.0D; anisometropia ≤ 2.0D) were divided into AG+CP or CP only groups. Participants performed a 2-hour e-book reading task using assigned AG+CP or CP only smartphones. Subjects' severity of DES pre- and post-reading were evaluated from two aspects: the degree of dry eye symptoms and asthenopia. Dry eye symptoms indicators (OSDI, TMH, NIBUT, FBUT, CFS, Schirmer I Test) and asthenopia indicators (CVSS17, Bulbar redness, HFC) were measured and compared.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The inclusion criteria required subjects to have myopia diopter not exceeding -6.00D, hyperopia not exceeding +2.0D, astigmatism not exceeding -2.00D, anisometropia between both eyes not exceeding 2.00D. The key exclusion criteria were as follows: (1) strabismus and amblyopia; (2) used eye drops within 1 week; (3) had undergone eye surgery within 6 months; (4) worn contact lenses within the last 2 weeks; (5) had serious eye discomfort in the last 7 days; (6) breastfeeding or pregnant women and patients with severe systemic diseases, psychosis or dementia. Subjects did not know the characteristics of the smartphones they use. The subjects were asked not to use video terminals such as mobile phones within 30 minutes before the study began.

Subjects were divided into 2 groups using AG+CP or CP only smartphone provided. During the whole experiment, subjects were in a room with 2 lux-environment illuminance, screen brightness about 10nit to mimic the situation before sleep. Light source stability (working surface illuminance fluctuation) greater than 99% during the whole experiment, desktop range uniformity greater than 80%. Indoor air conditioning control temperature: 22-25 degrees Celsius, humidity: 50-70%RH. Mobile phones were placed on a fixed holder (the angle and height of the phone holder can be adjusted to ensure the suitability of participants). All subjects' eyes were 40cm away from the mobile phone screen and seated on a chair of fixed position and appropriate height. Subjects were asked to finish 2-hour reading on the specific smartphone. Reading materials are downloaded in advance to the smartphone and presented using specific reading software and settings. During the study period, subjects were not allowed to do any behavior unrelated to watching the screen for a long time (more than 1 minute). All experiments were conducted between 8:00 and 11:00 to minimize the impact of electronic screen use during the day. Ocular surface disease index (OSDI), tear meniscus height (TMH), noninvasive tear break-up time (NIBUT), Fluorescein tear break-up time (FBUT), corneal fluorescein staining (CFS) and Schirmer I test were measured to evaluate the degree of dry eye symptom. Computer vision syndrome scale 17 (CVSS17), bulbar redness and high-frequency component of accommodative microfluctuations (HFC), were identified as assessment of asthenopia. The intervention and assessments were delivered both at before and after smartphone reading by qualified clinical ophthalmologists in a hospital setting.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Digital Eye Strain Computer Vision Syndrome Dry Eye Asthenopia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

yellow light AG group

use yellow light AG smartphone

Group Type EXPERIMENTAL

reading 2h on smartphone

Intervention Type BEHAVIORAL

reading 2h on smartphone

control group

use non-yellow light AG smartphone

Group Type PLACEBO_COMPARATOR

reading 2h on smartphone

Intervention Type BEHAVIORAL

reading 2h on smartphone

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

reading 2h on smartphone

reading 2h on smartphone

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1.have basic reading comprehension skills and to be older than 18 years old. 2.diopter of both eyes not exceeding -6.0D and anisometropia not exceeding 2.0D.

Exclusion Criteria

* 1.presbyopia or decreased regulation function, 2.ocular inflammation and disease, 3.worn contact lens within 1 month, 4.history of eye surgery within 6 months, 5.lactating or pregnant woman, 6.have severe systemic diseases.
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Second Affiliated Hospital Zhejiang University School of Medicine (SAHZU)

Hangzhou, Zhejiang, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jin

Role: CONTACT

13989455778

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Xiuming Jin

Role: primary

13989455778

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2025-1513

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Computer Screen Properties Study
NCT05042960 COMPLETED NA